Invectys Therapeutics
Tama Charlorin is an experienced professional in the pharmaceutical and biomanufacturing fields. Currently serving as a Technicienne de Recherche at Invectys since September 2016, Tama previously worked as a Technicienne en production pharmaceutique at LFB Biomanufacturing from March 2015 to December 2017. Tama holds a Licence Professionnelle in Développement Industriel et Production Pharmaceutique from Faculté de la Pharmacie Paris Sud 11, achieved in 2014, and a BTS in Qualité en Industries Alimentaires et Bio-Industries from Lycée Paul Eluard, completed in 2013.
This person is not in any offices
Invectys Therapeutics
Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers. It was founded in 2010 by Pierre Langlade Demoyen and Simon Wayne-Hobson and is based in Paris.Invectys develops a novel approach to mobilizing and restoring the anti-tumor capacity of the immune system of cancer patients.This allows virtually all cancers to be targeted. Invectys focuses its efforts on two highly prevalent tumor antigens: the nearly-universal tumor antigen telomerase that is critical to uncontrolled cell growth, and the HLA-G immune checkpoint expressed in over 50% of cancers.